Cargando…
Somatic mutations of thymic epithelial tumors with myasthenia gravis
BACKGROUND: Thymic epithelial tumors are rare malignant neoplasms that are frequently associated with paraneoplastic syndromes, especially myasthenia gravis. GTF2I is an oncogene mutated in a subgroup of thymomas that is reputed to drive their growth. However, for GTF2I wild-type tumors, the relevan...
Autores principales: | Pardini, Eleonora, Cucchiara, Federico, Palumbo, Sara, Tarrini, Giulia, Di Vita, Alessia, Coppedè, Fabio, Nicolì, Vanessa, Guida, Melania, Maestri, Michelangelo, Ricciardi, Roberta, Aprile, Vittorio, Ambrogi, Marcello C., Barachini, Serena, Lucchi, Marco, Petrini, Iacopo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475716/ https://www.ncbi.nlm.nih.gov/pubmed/37671056 http://dx.doi.org/10.3389/fonc.2023.1224491 |
Ejemplares similares
-
Preferential X Chromosome Inactivation as a Mechanism to Explain Female Preponderance in Myasthenia Gravis
por: Nicolì, Vanessa, et al.
Publicado: (2022) -
Investigation of MLH1, MGMT, CDKN2A, and RASSF1A Gene Methylation in Thymomas From Patients With Myasthenia Gravis
por: Coppedè, Fabio, et al.
Publicado: (2020) -
Gene-Specific Methylation Analysis in Thymomas of Patients with Myasthenia Gravis
por: Lopomo, Angela, et al.
Publicado: (2016) -
Clinical correlates and outcomes of coronavirus disease in a cohort of myasthenia gravis patients
por: Latini, Ester, et al.
Publicado: (2021) -
Thymoma‐associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma
por: De Rosa, Anna, et al.
Publicado: (2020)